Critical illnesses have a significant impact on overall survival among patients with cancer

the ONA take:

A new study from researchers at the University of Glasgow found 1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis, and a quarter of them died in hospital. In addition, this risk increased with age.

Using cancer registry and hospital data from Scotland spanning 10 years, the researchers captured information on more than 118,500 people with cancer, including 6,116 who were admitted to ICU.

Study findings showed that risk of ICU admission was highest among patients with GI cancer and lowest in patients with prostate cancer, breast cancer, and melanoma of the skin.

Mortality was higher among emergency medical admissions, and those who received organ support compared with those who did not receive organ support.

Deaths during hospital stays was higher among patients with cancers of unknown primary cause, lung cancer, and liver cancer, but those with head and neck cancers, multiple cancers, kidney cancer, and thyroid cancer had lower mortality rates.

The study indicates that critical illness may play a role in overall cancer outcomes. The researchers suggest that if ICUs can effectively reduce the risk of dying following a critical illness, increased surveillance for early signs of critical illness and access to ICU care for patients with cancer may improve overall survival rates.

A genetic variation in the FOPNL gene can decrease MM survival.
1 in 20 patients with cancer were admitted to the intensive care unit (ICU) for a critical illness within 2 years of their diagnosis.
Critical illness may affect chances of surviving cancer, a new study has found. Researchers at the University of Glasgow found 1 in 20 patients with a tumour were admitted to an intensive care unit (ICU) within two years of their diagnosis - with a quarter dying in hospital.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs